ALT normalization at 1 year seemed to be useful for HCC prediction in both genotypes C and B, although the difference in the cumulative HCC incidence in genotype B patients was not statistically significant (genotype C, p < 0.001; genotype B, p = 0.081) because of the low number of HCC patients. This evidence concerns the gene GPT and hepatocellular carcinoma.